TY  - JOUR

T1  - Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

JO  - Journal of Dermatological Treatment

UR  - http://eprints.whiterose.ac.uk/150175/

PY  - 2019/06/09

AU  - Cork MJ

AU  - Eckert L

AU  - Simpson EL

AU  - Armstrong A

AU  - Barbarot S

AU  - Puig L

AU  - Girolomoni G

AU  - de Bruin-Weller M

AU  - Wollenberg A

AU  - Kataoka Y

AU  - Remitz A et al

ED  - 

DO  - DOI: 10.1080/09546634.2019.1612836

PB  - Informa UK Limited

Y2  - 2024/12/22

ER  -